Viewing Study NCT05469360


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-05-29 @ 6:11 AM
Study NCT ID: NCT05469360
Status: RECRUITING
Last Update Posted: 2025-08-28
First Post: 2022-07-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CNIO752B12201
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators